Transgene Biotek LimitedBSE: TRABI

Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 07, 2026.

· Issued by Transgene Biotek Limited via BSE India

Filed with BSE ·

Sub: Outcome of the Meeting of the Board of Directors held on August 07, 2026.This has reference to our letter dated 22nd July 2026, Intimating the meeting of the Board of Directors of the Company.At a meeting of the Board of Directors of the company held on 07th August 2026 the following decisions have been taken:1) The Board considered and approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2026.2) The Board considered and approved the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30th June 2026.3) The Board considered and approved the extension of the date of Annual General Meeting (AGM) of the Company for the financial year 2025-26, subject to obtaining the necessary approval from the Registrar of Companies, wherever applicable.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Transgene Biotek Limited on 6ix

Earlier from Transgene Biotek

Later from Transgene Biotek

All Transgene Biotek news releases